Follow the Money: Tom Biscardi says "Hoax of the Century" Exposed a 60-Year Cash Cow Behind Bigfoot -- and Warns "Capturing Bigfoot" is Just More of the Same
Source: PR Newswire

Tom Biscardi, CEO of Searching for Bigfoot, is re-releasing his 14-year-old documentary "Hoax of the Century," alleging the 1967 Patterson-Gimlin Bigfoot film supported a nearly 60-year commercial ecosystem of books, appearances, licensing and merchandising. The PR release coincides with renewed attention to the documentary "Capturing Bigfoot" and includes unverified allegations that industry participants knowingly perpetuated a hoax and that Biscardi's family received threats. The item is promotional entertainment news with no material public-markets implication.
Analysis
This is non-investable promotional content with no identifiable transmission mechanism to Philip Morris (PM), despite the ticker tag. The claimed commercial ecosystem is fragmented, private, and immaterial to listed-media earnings; allegations are not independently adjudicated and should not be treated as evidence of legal liability, advertising disruption, or a licensing-revenue reset.
The only plausible market implication is a negligible, short-lived attention benefit for niche documentary distribution or digital-content platforms if mainstream coverage expands, but no public issuer has sufficient disclosed exposure to support a position. A genuine trade signal would require verified consumer boycotts, litigation filings against a listed media owner, or disclosed revenue concentration tied to the relevant intellectual property; none is present. Over a 6-18 month horizon, the larger lesson is reputational rather than financial: sensational press releases can create social-media volume without investable earnings revisions.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mixed
Sentiment Score
-0.10
Key Decisions for Investors
- No action in PM: maintain positions based on tobacco volume, U.S. nicotine regulation, IQOS commercialization, FX, and capital returns; this item provides no fundamental catalyst or revised earnings input.
- Do not initiate a media/entertainment long or short from this release. Set an event-driven alert only for a named, listed distributor or platform reporting material viewership, licensing revenue, or litigation exposure connected to the documentary.
- If the story produces an unusual pre-market move in any tagged security, fade only after confirming there is no issuer-specific disclosure; invalidate the fade if a filing, formal legal complaint, or quantified revenue exposure emerges.
More News
- Paramount will need to release way more movies to make this merger work
- U.S. regulators rush to write crypto rulebook after Clarity Act stalls in Senate
- Meta’s Muse AI is exploding in popularity—and already drawing heated backlash from another tech giant
- NYC Mayor Mamdani reaches record DoorDash settlement for underpaid workers
- Paramount Settlement Triggers WBD Breakout. How It Compares To Past Media Mergers.
- CNN staffers panic over Paramount merger as layoffs loom in months ahead: ‘Bloodbath coming'
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Best AI Stock Research Tools for Professional Investors
- Weekly Update: Adding Live MBO Level 3 Data - Liquidity Heatmap, OFI Charts, and More